As September marks Prostate Cancer Awareness Month, it’s crucial to remember a key point highlighted by MidLantic Urology: a PSA increase of 0.75 in one year could indicate prostate cancer and prompt a visit to a urologist for further evaluation.
Gregory C. McMahon, D.O.
Dr. Gregory McMahon, an Advanced Prostate Cancer Physician Champion at MidLantic Urology, stresses the importance of monitoring PSA levels and their rate of change. Some individuals with high PSA levels may not have cancer, while others with lower levels might. Regular monitoring and early detection are key in saving lives.
Both noncancerous and cancerous prostate cells produce PSA, with cancerous cells typically generating higher levels. The PSA blood test, combined with a digital rectal exam, remains the most effective method of detecting prostate cancer.
Getting a PSA Test
Your primary care physician or any of MidLantic Urology’s numerous specialists can provide a PSA test and digital rectal exam.
Treatment Options
MidLantic Urology offers comprehensive treatment for both early-stage and advanced prostate cancer, with a dedicated team of specialists trained in the latest techniques.
Risk Factors
Prostate cancer can affect men of all ages, with a significant number of cases diagnosed in those under 65. Early screening is recommended, especially for individuals with specific risk factors such as race, family history, and lifestyle choices.
It’s essential not to delay the PSA test, as all men are at risk of prostate cancer. Join MidLantic Urology and ZERO® Prostate Cancer for the Run/Walk event on September 29th to raise awareness and support the cause.
Participate in the ZERO Prostate Cancer Run/Walk on Sept 29
On September 29th, join MidLantic Urology and ZERO® Prostate Cancer for the Run/Walk event at Wilson Farm Park in Wayne, Pennsylvania. Visit support.zerocancer.org to sign up or donate.